Antitumor Effect of Bevacizumab in a Xenograft Model of Canine Hemangiopericytoma

• Main Authors: Masaki Michishita (Author), Tatsuya Uto (Author), Ryota Nakazawa (Author), Hisashi Yoshimura (Author), Kikumi Ogihara (Author), Yuko Naya (Author), Tsuyoshi Tajima (Author), Daigo Azakami (Author), Seigo Kishikawa (Author), Toshiro Arai (Author), Kimimasa Takahashi (Author)
• Format: Book
• Published: Elsevier, 2013-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract.: Canine hemangiopericytoma (CHP) is characterized by frequent local recurrence and increased invasiveness. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis in tumors. The aim of the present study was to investigate the effect of a single dose of bevacizumab on a...